CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.1%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$8.04B
AUM Growth
+$8.04B
(+2.1%)
Cap. Flow
-$241M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
72.74%
Holding
123
New
10
Increased
29
Reduced
37
Closed
41
Top Buys
| 1 |
MSCI
MSCI
|
$183M |
| 2 |
Elevance Health
ELV
|
$31.9M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$15.2M |
| 4 |
Intuitive Surgical
ISRG
|
$15.1M |
| 5 |
Teleflex
TFX
|
$14.9M |
Top Sells
| 1 |
Visa
V
|
$148M |
| 2 |
Johnson & Johnson
JNJ
|
$46.1M |
| 3 |
Ecolab
ECL
|
$44.2M |
| 4 |
UnitedHealth
UNH
|
$33.9M |
| 5 |
Pfizer
PFE
|
$33.4M |
Sector Composition
| 1 | Financials | 24.06% |
| 2 | Consumer Discretionary | 16.59% |
| 3 | Healthcare | 13.94% |
| 4 | Consumer Staples | 10.32% |
| 5 | Materials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $22.2M | 0.28% | 264,955 -65,000 | -20% | -$5.45M |
|
|
27
Intuitive Surgical
ISRG
$170B
| $22M | 0.27% | 41,937 +28,800 | +219% | +$15.1M |
|
28
Exact Sciences
EXAS
$8.98B
| $21.1M | 0.26% | 178,932 +120,000 | +204% | +$14.2M |
|
29
Illumina
ILMN
$15.8B
| $20.1M | 0.25% | 54,505 +40,000 | +276% | +$14.7M |
|
30
DexCom
DXCM
$29.5B
| $18.3M | 0.23% | 121,949 +95,000 | +353% | +$14.2M |
|
31
Insulet
PODD
$23.9B
| $18.2M | 0.23% | 152,672 +100,000 | +190% | +$11.9M |
|
32
Sarepta Therapeutics
SRPT
$1.78B
| $17.5M | 0.22% | 115,329 +90,000 | +355% | +$13.7M |
|
33
Centene
CNC
$14.3B
| $16.6M | 0.21% | 317,306 +130,000 | +69% | +$6.82M |
|
34
Glaukos
GKOS
$5.5B
| $15.8M | 0.2% | 209,265 +165,000 | +373% | +$12.4M |
|
35
Teladoc Health
TDOC
$1.37B
| $15.6M | 0.19% | 234,834 +130,000 | +124% | +$8.63M |
|
|
TVRD
36
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $15.1M | 0.19% | 703,460 +560,000 | +390% | +$12M |
|
37
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $15M | 0.19% | 678,464 +480,000 | +242% | +$10.6M |
|
|
38
Teleflex
TFX
$5.59B
| $14.9M | 0.19% | +45,000 | New | +$14.9M |
|
|
AMRN
39
Amarin Corp
AMRN
$311M
| $14.8M | 0.18% | 761,329 | – | – |
|
40
Humana
HUM
$36.5B
| $14.6M | 0.18% | +55,000 | New | +$14.6M |
|
41
BioMarin Pharmaceuticals
BMRN
$11.2B
| $14M | 0.17% | 163,851 +95,000 | +138% | +$8.14M |
|
|
BHVN
42
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $13.7M | 0.17% | 311,751 -70,000 | -18% | -$3.07M |
|
|
AERI
43
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $13.5M | 0.17% | 456,142 +320,000 | +235% | +$9.46M |
|
|
LHCG
44
DELISTED
LHC Group LLC
LHCG
| $13.2M | 0.16% | 110,657 +65,000 | +142% | +$7.77M |
|
45
NovoCure
NVCR
$1.38B
| $13.2M | 0.16% | 208,059 +100,000 | +93% | +$6.32M |
|
|
STML
46
DELISTED
Stemline Therapeutics, Inc.
STML
| $13.1M | 0.16% | 858,082 +500,000 | +140% | +$7.66M |
|
47
Heron Therapeutics
HRTX
$207M
| $13.1M | 0.16% | 702,069 +450,000 | +179% | +$8.37M |
|
48
Vertex Pharmaceuticals
VRTX
$100B
| $12.6M | 0.16% | 68,557 | – | – |
|
|
AXDX
49
DELISTED
Accelerate Diagnostics
AXDX
| $12M | 0.15% | 524,683 +410,000 | +358% | +$9.38M |
|
|
HZNP
50
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.8M | 0.15% | 491,544 +300,000 | +157% | +$7.22M |
|